PDE8A Blocking Peptide peptide (STJ504674)
SPECIFICATIONS
ImmunogenSynthetic cyclic peptide from mid-region common to all PDE8A variants.
General Information
| Short Description | PDE8A Blocking Peptide is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Dilution Range | WB: IP: 1:250IHC: 1:250ICC: 1:250IF: 1:250CFM: 1:250 |
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic cyclic peptide from mid-region common to all PDE8A variants. |
Additional Info
| Background | Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in maintaining basal levels of the cyclic nucleotide and/or in the cAMP regulation of germ cell development. |
Information sourced from Uniprot.org